International Conference on Diabetes Conference Melbourne 2018
June 07-09, 2018 Hyderabad, India
Conference | Home
Download Brochure
About Conference
OCM Members
Scientific Tracks
Abstract Submission
Important Dates

About the Conference

Citation International is organizing an International Conference on Diabetes & obesity to be held in Melbourne, Australia from November 26-28, 2018.The main theme of these conference is to escalate the new researches about Diabetes & obesity and evolution taking in the future in development .The objective of this conference is to provide knowledge to the students and to share the knowledge about the development and technologies implementing in Diabetes & obesity by the researchers and scientists share the innovative ideas for the improvement in nursing to provide better service for the patients. We would like to invite and be a part of this conference it will be a good platform to gain knowledge in the Diabetes & obesity You’ll be inspired by means of pinnacle speakers and innovators inside the area who will proportion new ideas to recharge your profession

Why to Attend?

It is a significant passage to debate problems with conjoined concern, exchange views, share ideas and generate solutions to existing or probable challenges within the field. Noted care practitioners, registered nurses, professors, research people, students and delegates, WHO area unit seeking updates and discussions within the recent trends; WHO would love to fulfill and connect with top-seeded professionals students and dentists can have wonderful opportunities to quench their thirst to achieve data, latest technologies and future development implementing in nursing in upcoming years. It will be a great platform to know the latest researches going in Dentistry at present and in future and the knowledge shared by the speakers.

Importance and Scope of  Diabetes & obesity.

Once the Cinderella of chronic diseases, diabetes is now at last receiving well-deserved prominence as it becomes epidemic. At the same time, obesity has reached epidemic proportions globally, and the situation is likely to get worse. In developed regions, such as Europe, the United States, and Australia, the prevalence is high and increasing

Type 2 diabetes is a global health problem of enormous magnitude, especially in newly industrialized and developing nations and minorities in developed countries. The last 4 decades have seen mounting epidemics of type 2 diabetes in traditional living populations as their lifestyle has changed from subsistence agriculture to a modern "Western" pattern, a process associated with the globalization of the world economy. Type 2 diabetes is poised to become one of the major challenges to public health in the 21st Century and will result in a huge economic burden, particularly in developing nations, through premature morbidity and mortality.

Market Report:

The global diabetes treatment market is undergoing significant transition driven by the advent of new analytical technologies and developments in diabetes treatment. There has been a drastic increase in the incidents of diabetes worldwide, owing to the rising level of sedentary lifestyles and obesity in global population. The sub markets such the human insulin and analogues are expected to maintain dominance in the overall diabetes treatment market. The diabetes treatment products include injectable diabetes drugs, oral drugs, insulin therapies, insulin pumps, insulin injection devices and blood glucose monitoring systems. In addition, substantial number of emerging diabetes drugs is under clinical observation by large pharmaceutical companies which are expected to enter the market within the forecast period. In blood glucose treatment, drugs such as januvia and byetta, have exhibited efficacy profiles and good safety. In order to manage the critical insulin therapy virtually less painful, accurate, easy to use, and improved blood glucose monitoring systems are available in the market. Increase in incidence of type one and type two diabetes, is expected to fuel the diabetes treatment market. In addition, development of type one and type two diabetes treatments are expected to remain profitable for the pharmaceutical companies in long or short term.

Weight loss and diet management is a challenge for millions of people around the world. Globally, more than 1 billion people are above an ideal weight. In addition to the negative social effects being overweight has on an individual, the health effects can be deadly. The affects weight has on life-threatening or life-altering disease are devastating. Diseases such as diabetes, heart disease, and cancer all have links to being overweight or obese. Increasing education efforts, accessible weight management plans and foods, and a growing desire to be physically desirable have fueled this market in more recent years. More than 100 million people in the United States are actively involved in a weight loss or weight management plan at any one time throughout the year. This suggests a demand for products and services which will continue for years to come. The definitions or measurement characteristics for overweight and obesity have varied over time. The varied definitions affect prevalence statistics and make it difficult to compare data from different studies. The prevalence of overweight and obesity is commonly assessed by using body mass index (BMI). A BMI over 25 kg/m2 is defined as overweight, and a BMI of over 30 kg/m2 as obese. These markers provide the common benchmarks for assessment, but the risks of disease in all populations can increase progressively from lower BMI levels.

According to the World Health Organization, adult mean BMI levels of 22-23 kg.m2 are found in Africa and Asia, while levels of 25-27 kg.m2 are prevalent across North America, Europe, and in some Latin American, North African and Pacific Island countries. BMI increases among middle-aged elderly people, who are at the greatest risk of health complications. In countries undergoing nutrition transition, overnutrition often coexists with undernutrition. People with a BMI below 18.5 kg/m2 tend to be underweight.

Target Audience





Business Professionals

Academic Professionals



Medical and Pharma Companies

Medical Colleges and Hospitals

Diabetes Societies and Associations




Attention to Authors

Abstracts/Articles will be published in ISBN Book No. 978-93-5288-788-0 and Selected articles will be published in ISSN International Journal of Business Research and Management Practice and International Journal of Economics and Finance.